{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T23:10:14Z","timestamp":1794611414053,"version":"4.9.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T00:00:00Z","timestamp":1498521600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T00:00:00Z","timestamp":1498521600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["Intramural Program"],"award-info":[{"award-number":["Intramural Program"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12974-017-0901-y","type":"journal-article","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T09:43:41Z","timestamp":1498556621000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Protease-activated receptor-1 activation by granzyme B causes neurotoxicity that is augmented by interleukin-1\u03b2"],"prefix":"10.1186","volume":"14","author":[{"given":"Paul R.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tory P.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmilee","family":"Gnanapavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Giovannoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongguang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph P.","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Medynets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Vaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Gartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avindra","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,27]]},"reference":[{"key":"901_CR1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/ana.410310317","volume":"31","author":"DW Anderson","year":"1992","unstructured":"Anderson DW, Ellenberg JH, Leventhal CM, et al. Revised estimate of the prevalence of multiple sclerosis in the United States. Ann Neurol. 1992;31:333\u20136.","journal-title":"Ann Neurol."},{"key":"901_CR2","doi-asserted-by":"publisher","first-page":"939","DOI":"10.2967\/jnumed.113.131698","volume":"55","author":"E Rissanen","year":"2014","unstructured":"Rissanen E, Tuisku J, Rokka J, et al. In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand 11C-PK11195. J Nucl Med. 2014;55:939\u201344.","journal-title":"J Nucl Med."},{"key":"901_CR3","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1136\/jnnp-2012-304094","volume":"84","author":"V Popescu","year":"2013","unstructured":"Popescu V, Agosta F, Hulst HE, et al. Brain atrophy and lesion load predict long term disability in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2013;84:1082\u201391.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"901_CR4","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ejpn.2013.12.002","volume":"18","author":"A Fern\u00e1ndez-Ja\u00e9n","year":"2014","unstructured":"Fern\u00e1ndez-Ja\u00e9n A, Fern\u00e1ndez-Mayoralas DM, Fern\u00e1ndez-Perrone AL, et al. Cortical thickness at the time of the initial attack in two patients with paediatric relapsing-remitting multiple sclerosis. Eur J Paediatr Neurol. 2014;18:295\u2013300. doi:\n                    10.1016\/j.ejpn.2013.12.002\n                    \n                  .","journal-title":"Eur J Paediatr Neurol."},{"key":"901_CR5","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1212\/WNL.0b013e3181e24136","volume":"74","author":"N De Stefano","year":"2010","unstructured":"De Stefano N, Giorgio A, Battaglini M, et al. Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes. Neurology. 2010;74:1868\u201376.","journal-title":"Neurology"},{"key":"901_CR6","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1093\/brain\/aws246","volume":"135","author":"M Calabrese","year":"2012","unstructured":"Calabrese M, Poretto V, Favaretto A, et al. Cortical lesion load associates with progression of disability in multiple sclerosis. Brain. 2012;135:2952\u201361.","journal-title":"Brain."},{"key":"901_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4161\/pri.23499","volume":"7","author":"R Klaver","year":"2013","unstructured":"Klaver R, De Vries HE, Schenk GJ, Geurts JJ. Grey matter damage in multiple sclerosis: a pathology perspective. Prion. 2013;7:66\u201375.","journal-title":"Prion."},{"key":"901_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1515\/BC.2003.021","volume":"384","author":"H Wang","year":"2003","unstructured":"Wang H, Reiser G. Thrombin signaling in the brain: the role of protease-activated receptors. Biol Chem. 2003;384:193\u2013202.","journal-title":"Biol Chem."},{"key":"901_CR9","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/0092-8674(91)90261-V","volume":"64","author":"TK Vu","year":"1991","unstructured":"Vu TK, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 1991;64:1057\u201368.","journal-title":"Cell."},{"key":"901_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043950","author":"T Wang","year":"2012","unstructured":"Wang T, Lee MH, Choi E, et al. Granzyme B-induced neurotoxicity is mediated via activation of PAR-1 receptor and Kv1.3 channel. PLoS One. 2012. doi:\n                    10.1371\/journal.pone.0043950\n                    \n                  .","journal-title":"PLoS One"},{"key":"901_CR11","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/1096-9861(20010312)431:3<347::AID-CNE1075>3.0.CO;2-K","volume":"431","author":"IA Scarisbrick","year":"2001","unstructured":"Scarisbrick IA, Isackson PJ, Ciric B, Windebank AJ, Rodriguez M. MSP, a trypsin-like serine protease, is abundantly expressed in the human nervous system. J Comp Neurol. 2001;431:347\u201361.","journal-title":"J Comp Neurol."},{"key":"901_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nrd3615","volume":"11","author":"R Ramachandran","year":"2012","unstructured":"Ramachandran R, Noorbakhsh F, Defea K, Hollenberg MD. Targeting proteinase-activated receptors: therapeutic potential and challenges. Nat Rev Drug Discov. 2012;11:69\u201386.","journal-title":"Nat Rev Drug Discov."},{"key":"901_CR13","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.neuroscience.2007.02.059","volume":"146","author":"MC Olianas","year":"2007","unstructured":"Olianas MC, Dedoni S, Onali P. Proteinase-activated receptors 1 and 2 in rat olfactory system: layer-specific regulation of multiple signaling pathways in the main olfactory bulb and induction of neurite retraction in olfactory sensory neurons. Neuroscience. 2007;146:1289\u2013301.","journal-title":"Neuroscience."},{"key":"901_CR14","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1097\/01.WCB.0000128266.87474.BF","volume":"24","author":"EE Olson","year":"2004","unstructured":"Olson EE, Lyuboslavsky P, Traynelis SF, McKeon RJ. PAR-1 deficiency protects against neuronal damage and neurologic deficits after unilateral cerebral hypoxia\/ischemia. J Cereb Blood Flow Metab. 2004;24:964\u201371.","journal-title":"J Cereb Blood Flow Metab."},{"key":"901_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/jnc.12075","volume":"124","author":"AG Almonte","year":"2013","unstructured":"Almonte AG, Qadri LH, Sultan FA, Watson JA, Mount DJ, Rumbaugh G, Sweatt JD. Protease-activated receptor-1 modulates hippocampal memory formation and synaptic plasticity. J Neurochem. 2013;124:109\u201322.","journal-title":"J Neurochem."},{"key":"901_CR16","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1093\/brain\/awr242","volume":"134","author":"S Acharjee","year":"2011","unstructured":"Acharjee S, Zhu Y, Maingat F, et al. Proteinase-activated receptor-1 mediates dorsal root ganglion neuronal degeneration in HIV\/AIDS. Brain. 2011;134:3209\u201321.","journal-title":"Brain."},{"key":"901_CR17","doi-asserted-by":"crossref","first-page":"5316","DOI":"10.1523\/JNEUROSCI.17-14-05316.1997","volume":"17","author":"FM Donovan","year":"1997","unstructured":"Donovan FM, Pike CJ, Cotman CW, Cunningham DD. Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J Neurosci. 1997;17:5316\u201326.","journal-title":"J Neurosci."},{"key":"901_CR18","doi-asserted-by":"publisher","first-page":"5020","DOI":"10.1523\/JNEUROSCI.0311-10.2010","volume":"30","author":"T Wang","year":"2010","unstructured":"Wang T, Lee MH, Johnson T, et al. Activated T-cells inhibit neurogenesis by releasing granzyme B: rescue by Kv1.3 blockers. J Neurosci. 2010;30:5020\u20137.","journal-title":"J Neurosci."},{"key":"901_CR19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1468-1331.1997.tb00300.x","volume":"4","author":"F Sellebjerg","year":"1997","unstructured":"Sellebjerg F, Bendtzen K, Christiansen M, Frederiksen J. Cytokines and soluble IL-4 in patients with acute optic neuritis and multiple sclerosis. Eur J Neurol. 1997;4:59\u201367.","journal-title":"Eur J Neurol."},{"key":"901_CR20","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1093\/infdis\/175.3.689","volume":"175","author":"PD Mehta","year":"1997","unstructured":"Mehta PD, Kulczycki J, Mehta SP, et al. Increased levels of interleukin-1beta and soluble intercellular adhesion molecule-1 in cerebrospinal fluid of patients with subacute sclerosing panencephalitis. J Infect Dis. 1997;175:689\u201392.","journal-title":"J Infect Dis."},{"key":"901_CR21","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/ana.22512","volume":"71","author":"S Rossi","year":"2012","unstructured":"Rossi S, Furlan R, De Chiara V, et al. Interleukin-1\u03b2 causes synaptic hyperexcitability in multiple sclerosis. Ann Neurol. 2012;71:76\u201383.","journal-title":"Ann Neurol."},{"key":"901_CR22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jneuroim.2014.02.014","volume":"270","author":"D Seppi","year":"2014","unstructured":"Seppi D, Puthenparampil M, Federle L, et al. Cerebrospinal fluid IL-1\u03b2 correlates with cortical pathology load in multiple sclerosis at clinical onset. J Neuroimmunol. 2014;270:56\u201360.","journal-title":"J Neuroimmunol."},{"key":"901_CR23","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1111\/j.1528-1167.2008.01977.x","volume":"50","author":"Y Takahashi","year":"2009","unstructured":"Takahashi Y, Mine J, Kubota Y, Yamazaki E, Fujiwara T. A substantial number of Rasmussen syndrome patients have increased IgG, CD4+ T cells, TNFalpha, and Granzyme B in CSF. Epilepsia. 2009;50:1419\u201331.","journal-title":"Epilepsia."},{"key":"901_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070019","author":"S Gnanapavan","year":"2013","unstructured":"Gnanapavan S, Grant D, Morant S, et al. Biomarker report from the phase II lamotrigine trial in secondary progressive MS - neurofilament as a surrogate of disease progression. PLoS One. 2013. doi:\n                    10.1371\/journal.pone.0070019\n                    \n                  .","journal-title":"PLoS One"},{"key":"901_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1559-0275-9-9","author":"Y Jia","year":"2012","unstructured":"Jia Y, Wu T, Jelinek CA, et al. Development of protein biomarkers in cerebrospinal fluid for secondary progressive multiple sclerosis using selected reaction monitoring mass spectrometry (SRM-MS). Clin Proteomics. 2012. doi:\n                    10.1186\/1559-0275-9-9\n                    \n                  .","journal-title":"Clin Proteomics"},{"key":"901_CR26","series-title":"United States patent US CA2515715 A1","volume-title":"Methods for producing cyclic benzamidine derivatives","author":"N Shimormura","year":"2004","unstructured":"Shimormura N, Sasho M, Kayano A, inventors; Esai Co., Ltd., assignee, et al. Methods for producing cyclic benzamidine derivatives, United States patent US CA2515715 A1. 2004."},{"key":"901_CR27","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/(SICI)1097-0185(199803)250:3<373::AID-AR12>3.0.CO;2-L","volume":"250","author":"JC Hedreen","year":"1998","unstructured":"Hedreen JC. What was wrong with the Abercrombie and empirical cell counting methods? A review. Anat Rec. 1998;250:373\u201380.","journal-title":"Anat Rec."},{"key":"901_CR28","doi-asserted-by":"publisher","first-page":"11485","DOI":"10.1523\/JNEUROSCI.0210-14.2014","volume":"34","author":"M Bae","year":"2014","unstructured":"Bae M, Patel N, Xu H, et al. Activation of TRPML1 clears intraneuronal A\u03b2 in preclinical models of HIV infection. J Neurosci. 2014;34:11485\u2013503.","journal-title":"J Neurosci."},{"key":"901_CR29","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1096\/fj.05-5022fje","volume":"20","author":"T Wang","year":"2006","unstructured":"Wang T, Allie R, Conant K, et al. Granzyme B mediates neurotoxicity through a G-protein-coupled receptor. FASEB J. 2006;20:1209\u201311.","journal-title":"FASEB J."},{"key":"901_CR30","first-page":"455","volume":"13","author":"R Cacabelos","year":"1991","unstructured":"Cacabelos R, Barquero M, Garc\u00eda P, et al. Cerebrospinal fluid interleukin-1 beta (IL-1 beta) in Alzheimer's disease and neurological disorders. Methods Find Exp Clin Pharmacol. 1991;13:455\u20138.","journal-title":"Methods Find Exp Clin Pharmacol."},{"key":"901_CR31","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1097\/01.jnen.0000190067.20935.42","volume":"64","author":"M Vercellino","year":"2005","unstructured":"Vercellino M, Plano F, Votta B, et al. Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol. 2005;64:1101\u20137.","journal-title":"J Neuropathol Exp Neurol."},{"key":"901_CR32","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.expneurol.2004.02.018","volume":"188","author":"CE Junge","year":"2004","unstructured":"Junge CE, Lee CJ, Hubbard KB, et al. Protease-activated receptor-1 in human brain: localization and functional expression in astrocytes. Exp Neurol. 2004;188:94\u2013103.","journal-title":"Exp Neurol."},{"key":"901_CR33","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/gene.2011.3","volume":"12","author":"WS Bush","year":"2011","unstructured":"Bush WS, McCauley JL, DeJager PL, et al. A knowledge-driven interaction analysis reveals potential neurodegenerative mechanism of multiple sclerosis susceptibility. Genes Immun. 2011;12:335\u201340.","journal-title":"Genes Immun."},{"key":"901_CR34","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neuropharm.2013.07.037","volume":"75","author":"S Di Prisco","year":"2013","unstructured":"Di Prisco S, Merega E, Milanese M, et al. CCL5-glutamate interaction in central nervous system: Early and acute presynaptic defects in EAE mice. Neuropharmacology. 2013;75:337\u201346.","journal-title":"Neuropharmacology."},{"key":"901_CR35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.mvr.2014.04.011","volume":"98","author":"J Evans","year":"2015","unstructured":"Evans J, Ko Y, Mata W, et al. Arachidonic acid induces brain endothelial cell apoptosis via p38-MAPK and intracellular calcium signaling. Microvasc Res. 2015;98:145\u201358.","journal-title":"Microvasc Res."},{"key":"901_CR36","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1161\/STROKEAHA.108.540393","volume":"40","author":"M Xue","year":"2009","unstructured":"Xue M, Hollenberg MD, Demchuk A, Yong VW. Relative importance of proteinase-activated receptor-1 versus matrix metalloproteinases in intracerebral hemorrhage-mediated neurotoxicity in mice. Stroke. 2009;40:2199\u2013204.","journal-title":"Stroke."},{"key":"901_CR37","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1002\/glia.22534","volume":"61","author":"JE Burda","year":"2013","unstructured":"Burda JE, Radulovic M, Yoon H, Scarisbrick IA. Critical role for PAR-1 in kallikrein 6-mediated oligodendrogliopathy. Glia. 2013;61:1456\u201370.","journal-title":"Glia."},{"key":"901_CR38","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.bbrc.2006.05.174","volume":"346","author":"Y da Lee","year":"2006","unstructured":"da Lee Y, Park KW, Jin BK. Thrombin induces neurodegeneration and microglial activation in the cortex in vivo and in vitro: proteolytic and non-proteolytic actions. Biochem Biophys Res Commun. 2006;346:727\u201338.","journal-title":"Biochem Biophys Res Commun."},{"issue":"9","key":"901_CR39","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1179\/1743132812Y.0000000081","volume":"34","author":"V Shaygannejad","year":"2012","unstructured":"Shaygannejad V, Janghorbani M, Ashtari F, Zakeri H. Comparison of the effect of aspirin and amantadine for the treatment of fatigue in multiple sclerosis: a randomized, blinded, crossover study. Neurol Res. 2012;34(9):854\u20138.","journal-title":"Neurol Res"},{"key":"901_CR40","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1212\/01.WNL.0000156803.23698.9A","volume":"64","author":"DM Wingerchuk","year":"2005","unstructured":"Wingerchuk DM, Benarroch EE, O'Brien PC, et al. A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis. Neurology. 2005;64:1267\u20139.","journal-title":"Neurology."},{"key":"901_CR41","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.vph.2014.06.001","volume":"62","author":"MA Alberelli","year":"2014","unstructured":"Alberelli MA, De Candia E. Functional role of protease activated receptors in vascular biology. Vascul Pharmacol. 2014;62:72\u201381.","journal-title":"Vascul Pharmacol."},{"key":"901_CR42","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1161\/STROKEAHA.107.487769","volume":"38","author":"Y Kai","year":"2007","unstructured":"Kai Y, Hirano K, Maeda Y, et al. Prevention of the hypercontractile response to thrombin by proteinase-activated receptor-1 antagonist in subarachnoid hemorrhage. Stroke. 2007;38:3259\u201365.","journal-title":"Stroke."},{"key":"901_CR43","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1742-2094-11-32","volume":"11","author":"S Rossi","year":"2014","unstructured":"Rossi S, Studer V, Motta C, et al. Cerebrospinal fluid detection of interleukin-1\u03b2 in phase of remission predicts disease progression in multiple sclerosis. J Neuroinflammation. 2014;11:32.","journal-title":"J Neuroinflammation."},{"key":"901_CR44","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/jcbfm.2010.103","volume":"31","author":"J Galea","year":"2011","unstructured":"Galea J, Ogungbenro K, Hulme S, et al. Intravenous anakinra can achieve experimentally effective concentrations in the central nervous system within a therapeutic time window: results of a dose-ranging study. J Cereb Blood Flow Metab. 2011;31:439\u201347.","journal-title":"J Cereb Blood Flow Metab."},{"key":"901_CR45","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jneuroim.2008.11.004","volume":"207","author":"I Dujmovic","year":"2009","unstructured":"Dujmovic I, Mangano K, Pekmezovic T, et al. The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: The elevation of IL-1 receptor antagonist and IL-1 receptor type II after steroid therapy. J Neuroimmunol. 2009;207:101\u20136.","journal-title":"J Neuroimmunol."},{"key":"901_CR46","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1136\/jnnp.62.2.200-b","volume":"62","author":"R Voltz","year":"1997","unstructured":"Voltz R, Hartmann M, Spuler S, et al. Multiple sclerosis: longitudinal measurement of interleukin-1 receptor antagonist. J Neurol Neurosurg Psychiatry. 1997;62:200\u20131.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"901_CR47","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/ana.10519","volume":"53","author":"JL Takahashi","year":"2003","unstructured":"Takahashi JL, Giuliani F, Power C, et al. Interleukin-1beta promotes oligodendrocyte death through glutamate excitotoxicity. Ann Neurol. 2003;53:588\u201395.","journal-title":"Ann Neurol."},{"key":"901_CR48","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2353\/ajpath.2010.090722","volume":"176","author":"A Kroner","year":"2010","unstructured":"Kroner A, Ip CW, Thalhammer J, et al. Ectopic T-cell specificity and absence of perforin and granzyme B alleviate neural damage in oligodendrocyte mutant mice. Am J Pathol. 2010;176:549\u201355.","journal-title":"Am J Pathol."},{"key":"901_CR49","doi-asserted-by":"publisher","first-page":"e57820","DOI":"10.1371\/journal.pone.0057820","volume":"8","author":"J Romme Christensen","year":"2013","unstructured":"Romme Christensen J, B\u00f6rnsen L, Ratzer R, et al. Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression. PLoS One. 2013;8:e57820.","journal-title":"PLoS One."},{"key":"901_CR50","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3389\/fimmu.2016.00555","volume":"7","author":"S De Biasi","year":"2016","unstructured":"De Biasi S, Simone AM, Nasi M, et al. iNKT Cells in Secondary Progressive Multiple Sclerosis Patients Display Pro-inflammatory Profiles. Front Immunol. 2016;7:555.","journal-title":"Front Immunol."}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-017-0901-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-017-0901-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-017-0901-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T03:21:13Z","timestamp":1589512873000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-017-0901-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,27]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["901"],"URL":"https:\/\/doi.org\/10.1186\/s12974-017-0901-y","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,27]]},"assertion":[{"value":"22 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"131"}}